{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:09:19Z","timestamp":1782601759221,"version":"3.54.5"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,10,10]],"date-time":"2011-10-10T00:00:00Z","timestamp":1318204800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Clinicians often experience extrahepatic metastases associated with hepatocellular carcinoma (HCC), even if no evidence of intrahepatic recurrence after treatment is observed. We investigated the pretreatment predictors of extrahepatic metastases in HCC patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Patients diagnosed with HCC without evidence of extrahepatic metastases were prospectively enrolled. We evaluated the correlation between extrahepatic metastases and pretreatment clinical variables, including serum tumor markers.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 354 patients were included. Seventy-six patients (21%) had extrahepatic metastases during the observation period (median, 25.3 months; range, 0.6-51.3 months). Cox regression multivariate analysis showed that serum protein induced by vitamin K absence or antagonist-II (PIVKA-II) production levels, the intrahepatic tumor stage, platelet count, and portal vein thrombosis were independent risk factors for extrahepatic metastases. Patients with a PIVKA-II production \u2265 300 mAU\/mL had a 2.7-fold (95% confidence interval; 1.5-4.8; P &lt; 0.001) and 3.7-fold (95% confidence interval; 2.0-6.6; P &lt; 0.001) increased risk for extrahepatic metastases after adjustment for stage, platelet count, alpha-fetoprotein \u2265 400 ng\/mL, and portal vein thrombosis according to the AJCC and BCLC staging systems, respectively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>PIVKA-II production levels might be a good candidate predictive marker for extrahepatic HCC metastases, especially in patients with smaller and\/or fewer tumors in the liver with in stages regardless of serum alpha-fetoprotein.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2407-11-435","type":"journal-article","created":{"date-parts":[[2011,10,11]],"date-time":"2011-10-11T06:34:00Z","timestamp":1318314840000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Protein induced by vitamin K absence or antagonist-II production is a strong predictive marker for extrahepatic metastases in early hepatocellular carcinoma: a prospective evaluation"],"prefix":"10.1186","volume":"11","author":[{"given":"Hyun-Mi","family":"Bae","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong-Hoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Hwan","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon Jun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae Seog","family":"Heo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo-Suk","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,10,10]]},"reference":[{"key":"2934_CR1","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/bjs.1800830138","volume":"83","author":"ST Fan","year":"1996","unstructured":"Fan ST, Lai EC, Lo CM, Chu KM, Liu CL, Wong J: Hepatectomy with an ultrasonic dissector for hepatocellular carcinoma. Br J Surg. 1996, 83: 117-20. 10.1002\/bjs.1800830138.","journal-title":"Br J Surg"},{"key":"2934_CR2","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/ssu.2980090404","volume":"9","author":"M Makuuchi","year":"1993","unstructured":"Makuuchi M, Kosuge T, Takayama T, Yamazaki S, Kakazu T, Miyagawa S, Kawasaki S: Surgery for small liver cancers. Semin Surg Oncol. 1993, 9: 298-304. 10.1002\/ssu.2980090404.","journal-title":"Semin Surg Oncol"},{"key":"2934_CR3","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJM199603143341104","volume":"334","author":"V Mazzaferro","year":"1996","unstructured":"Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A, Gennari L: Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996, 334: 693-9. 10.1056\/NEJM199603143341104.","journal-title":"N Engl J Med"},{"key":"2934_CR4","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1097\/00000658-200009000-00010","volume":"232","author":"SA Curley","year":"2000","unstructured":"Curley SA, Izzo F, Ellis LM, Nicolas Vauthey J, Vallone P: Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg. 2000, 232: 381-91. 10.1097\/00000658-200009000-00010.","journal-title":"Ann Surg"},{"key":"2934_CR5","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1053\/jhep.2002.33156","volume":"35","author":"CM Lo","year":"2002","unstructured":"Lo CM, Ngan H, Tso WK, Liu CL, Lam CM, Poon RT, Fan ST, Wong J: Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology. 2002, 35: 1164-71. 10.1053\/jhep.2002.33156.","journal-title":"Hepatology"},{"key":"2934_CR6","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1053\/jhep.2003.50047","volume":"37","author":"JM Llovet","year":"2003","unstructured":"Llovet JM, Bruix J: Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology. 2003, 37: 429-42. 10.1053\/jhep.2003.50047.","journal-title":"Hepatology"},{"key":"2934_CR7","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1097\/00000658-200203000-00009","volume":"235","author":"RT Poon","year":"2002","unstructured":"Poon RT, Fan ST, Lo CM, Liu CL, Wong J: Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Annals of surgery. 2002, 235: 373-82. 10.1097\/00000658-200203000-00009.","journal-title":"Annals of surgery"},{"key":"2934_CR8","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/hep.510250116","volume":"25","author":"T Kumada","year":"1997","unstructured":"Kumada T, Nakano S, Takeda I, Sugiyama K, Osada T, Kiriyama S, Sone Y, Toyoda H, Shimada S, Takahashi M, et al: Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma. Hepatology Baltimore, Md. 1997, 25: 87-92. 10.1002\/hep.510250116.","journal-title":"Hepatology Baltimore, Md"},{"key":"2934_CR9","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/nm843","volume":"9","author":"QH Ye","year":"2003","unstructured":"Ye QH, Qin LX, Forgues M, He P, Kim JW, Peng AC, Simon R, Li Y, Robles AI, Chen Y, et al: Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nature medicine. 2003, 9: 416-23. 10.1038\/nm843.","journal-title":"Nature medicine"},{"key":"2934_CR10","doi-asserted-by":"publisher","first-page":"4293","DOI":"10.1200\/JCO.2005.01.3441","volume":"24","author":"GK Abou-Alfa","year":"2006","unstructured":"Abou-Alfa GK, Schwartz L, Ricci S, et al: Phase II study of sorafenib in patients with advanced hepatocellular carcinoma. J Clin Oncol. 2006, 24: 4293-300. 10.1200\/JCO.2005.01.3441.","journal-title":"J Clin Oncol"},{"key":"2934_CR11","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1200\/JCO.2005.06.124","volume":"23","author":"D Strumberg","year":"2005","unstructured":"Strumberg D, Richly H, Hilger RA, Schleucher N, Korfee S, Tewes M, Faghih M, Brendel E, Voliotis D, Haase CG, et al: Phase I clinical and pharmacokinetic study of the Novel Raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43-9006 in patients with advanced refractory solid tumors. J Clin Oncol. 2005, 23: 965-72.","journal-title":"J Clin Oncol"},{"key":"2934_CR12","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/cncr.23175","volume":"112","author":"AX Zhu","year":"2008","unstructured":"Zhu AX: Development of sorafenib and other molecularly targeted agents in hepatocellular carcinoma. Cancer. 2008, 112: 250-9. 10.1002\/cncr.23175.","journal-title":"Cancer"},{"issue":"6","key":"2934_CR13","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1200\/JCO.20.6.1527","volume":"15;20","author":"JN Vauthey","year":"2002","unstructured":"Vauthey JN, Lauwers GY, Esnaola NF, Do KA, Belghiti J, Mirza N, Curley SA, Ellis LM, Regimbeau JM, Rashid A, et al: Simplified staging for hepatocellular carcinoma. J Clin Oncol. 2002, 15;20 (6): 1527-36.","journal-title":"J Clin Oncol"},{"key":"2934_CR14","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1055\/s-2007-1007122","volume":"19","author":"JM Llovet","year":"1999","unstructured":"Llovet JM, Bru C, Bruix J: Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis. 1999, 19: 329-38. 10.1055\/s-2007-1007122.","journal-title":"Semin Liver Dis"},{"key":"2934_CR15","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.transproceed.2004.12.030","volume":"37","author":"M Shimada","year":"2005","unstructured":"Shimada M, Yonemura Y, Ijichi H, Harada N, Shiotani S, Ninomiya M, Terashi T, Yoshizumi T, Soejima Y, Maehara Y: Living donor liver transplantation for hepatocellular carcinoma: a special reference to a preoperative Protein induced by vitamin K absence or antagonist-II value. Transplant Proc. 2005, 37: 1177-9. 10.1016\/j.transproceed.2004.12.030.","journal-title":"Transplant Proc"},{"key":"2934_CR16","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/jso.20655","volume":"95","author":"K Shirabe","year":"2007","unstructured":"Shirabe K, Itoh S, Yoshizumi T, Soejima Y, Taketomi A, Aishima S, Maehara Y: The predictors of microvascular invasion in candidates for liver transplantation with hepatocellular carcinoma-with special reference to the serum levels of des-gamma-carboxy prothrombin. J Surg Oncol. 2007, 95: 235-40. 10.1002\/jso.20655.","journal-title":"J Surg Oncol"},{"key":"2934_CR17","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S1386-6346(01)00150-4","volume":"22","author":"M Tamano","year":"2002","unstructured":"Tamano M, Sugaya H, Oguma M, Iijima M, Yoneda M, Murohisa T, Kojima K, Kuniyoshi T, Majima Y, Hashimoto T, et al: Serum and tissue PIVKA-II expression reflect the biological malignant potential of small hepatocellular carcinoma. Hepatol Res. 2002, 22: 261-9. 10.1016\/S1386-6346(01)00150-4.","journal-title":"Hepatol Res"},{"key":"2934_CR18","doi-asserted-by":"publisher","first-page":"8741","DOI":"10.1074\/jbc.M609358200","volume":"282","author":"T Fujikawa","year":"2007","unstructured":"Fujikawa T, Shiraha H, Ueda N, Takaoka N, Nakanishi Y, Matsuo N, Tanaka S, Nishina S, Suzuki M, Takaki A, et al: Des-gamma-carboxyl prothrombin-promoted vascular endothelial cell proliferation and migration. J Biol Chem. 2007, 282: 8741-8. 10.1074\/jbc.M609358200.","journal-title":"J Biol Chem"},{"key":"2934_CR19","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1002\/(SICI)1097-0142(19960515)77:10<2022::AID-CNCR9>3.0.CO;2-S","volume":"77","author":"E Adachi","year":"1996","unstructured":"Adachi E, Maeda T, Kajiyama K, Kinukawa N, Matsumata T, Sugimachi K, Tsuneyoshi M: Factors correlated with portal venous invasion by hepatocellular carcinoma: univariate and multivariate analyses of 232 resected cases without preoperative treatments. Cancer. 1996, 77: 2022-31. 10.1002\/(SICI)1097-0142(19960515)77:10<2022::AID-CNCR9>3.0.CO;2-S.","journal-title":"Cancer"},{"key":"2934_CR20","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1007\/s00535-006-1950-7","volume":"41","author":"S Hagiwara","year":"2006","unstructured":"Hagiwara S, Kudo M, Kawasaki T, Nagashima M, Minami Y, Chung H, Fukunaga T, Kitano M, Nakatani T: Prognostic factors for portal venous invasion in patients with hepatocellular carcinoma. J Gastroenterol. 2006, 41: 1214-9.","journal-title":"J Gastroenterol"},{"key":"2934_CR21","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/1097-0142(20010201)91:3<561::AID-CNCR1035>3.0.CO;2-N","volume":"91","author":"Y Koike","year":"2001","unstructured":"Koike Y, Shiratori Y, Sato S, Obi S, Teratani T, Imamura M, Yoshida H, Shiina S, Omata M: Protein induced by vitamin K absence or antagonist-II as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma: a prospective analysis of 227 patients. Cancer. 2001, 91: 561-9. 10.1002\/1097-0142(20010201)91:3<561::AID-CNCR1035>3.0.CO;2-N.","journal-title":"Cancer"},{"key":"2934_CR22","first-page":"2464","volume":"73","author":"T Suehiro","year":"1994","unstructured":"Suehiro T, Sugimachi K, Matsumata T, Itasaka H, Taketomi A, Maeda T: Protein induced by vitamin K absence or antagonist II as a prognostic marker in hepatocellular carcinoma. Comparison with alpha-fetoprotein. Cancer. 1994, 73: 2464-71.","journal-title":"Comparison with alpha-fetoprotein. Cancer"},{"key":"2934_CR23","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/nm1377","volume":"12","author":"JS Lee","year":"2006","unstructured":"Lee JS, Heo J, Libbrecht L, Chu IS, Kaposi-Novak P, Calvisi DF, Mikaelyan A, Roberts LR, Demetris AJ, Sun Z, et al: A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells. Nat Med. 2006, 12: 410-6. 10.1038\/nm1377.","journal-title":"Nat Med"},{"key":"2934_CR24","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00432-003-0511-1","volume":"130","author":"ZY Tang","year":"2004","unstructured":"Tang ZY, Ye SL, Liu YK, Qin LX, Sun HC, Ye QH, Wang L, Zhou J, Qiu SJ, Li Y, et al: A decade's studies on metastases of hepatocellular carcinoma. Journal of cancer research and clinical oncology. 2004, 130: 187-96. 10.1007\/s00432-003-0511-1.","journal-title":"Journal of cancer research and clinical oncology"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-11-435.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-11-435\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-11-435","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-11-435.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T20:51:04Z","timestamp":1630615864000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-11-435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,10]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["2934"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-11-435","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,10]]},"assertion":[{"value":"6 April 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"435"}}